46.46.Z - Wholesale trade of pharmaceutical and medical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.75.Z - Wholesale trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
52.10 - Warehousing and storage of goods
63.1 - Services related to computing infrastructure, data processing, website management (hosting), and related activities
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 147,7 | 152,5 | 97,3 | -36,2 |
EBITDA | 150,2 | 155 | 174 | 12,3 |
Short time liabilities | 848,5 | 776,1 | 822,7 | 6 |
Equity capital | 222 | 74,6 | 84,7 | 13,6 |
Operating profit (EBIT) | 133,1 | 147,1 | 167,3 | 13,7 |
Assets | 1106,9 | 880,2 | 939,4 | 6,7 |
Net profit (loss) | 115,4 | 118,5 | 59,2 | -50 |
Cash | 131 | 135,1 | 174,3 | 29,1 |
Net income from sale | 1936,1 | 1820,2 | 1698,1 | -6,7 |
Liabilities and provisions for liabilities | 885 | 805,7 | 854,7 | 6,1 |
Working assets | 1054,1 | 838,3 | 895,5 | 6,8 |
Depreciation | 17,1 | 7,9 | 6,7 | -15,3 |
% | % | % | p.p. | |
Profitability of capital | 52 | 158,9 | 69,9 | -89 |
Equity capital to total assets | 20,1 | 8,5 | 9 | 0,5 |
Gross profit margin | 7,6 | 8,4 | 5,7 | -2,7 |
EBITDA Margin | 7,8 | 8,5 | 10,2 | 1,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 160 | 156 | 177 | 21 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane